GlobalData on MSN
Quest Diagnostics’ Haystack MRD test secures NYSDOH approval
The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...
Quest is the largest reference laboratory to embed oncology molecular ordering into OncoEMR MPI, with projected reach to 4,700 clinicians across ~1,600 community oncology sites. Integration targets ...
Quest Diagnostics (NYSE:DGX) received New York State approval for its Haystack MRD liquid biopsy test, enabling nationwide use for detecting residual or recurrent cancer. The approval follows ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is integrating its ...
The U.S. Food and Drug Administration (FDA) on Saturday reissued an emergency use authorization to Quest Diagnostics to authorize a coronavirus test with pooled samples. In an FDA news release, ...
HealthTap and Quest Diagnostics are partnering to add lab tests to HealthTap's video visits. Doctors on HealthTap's platform will be able to order diagnostic tests for their patients, who can then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results